サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/02/28 | 1,235 | 1,242 | 1,220 | 1,221 | -14 | -1.1% | 142,200 |
| 2017/02/27 | 1,219 | 1,255 | 1,213 | 1,235 | +10 | +0.8% | 282,800 |
| 2017/02/24 | 1,224 | 1,234 | 1,219 | 1,225 | +2 | +0.2% | 112,900 |
| 2017/02/23 | 1,226 | 1,231 | 1,219 | 1,223 | -3 | -0.2% | 117,400 |
| 2017/02/22 | 1,240 | 1,243 | 1,225 | 1,226 | -11 | -0.9% | 71,000 |
| 2017/02/21 | 1,233 | 1,245 | 1,229 | 1,237 | ±0 | ±0% | 53,600 |
| 2017/02/20 | 1,250 | 1,256 | 1,235 | 1,237 | -15 | -1.2% | 77,100 |
| 2017/02/17 | 1,242 | 1,261 | 1,242 | 1,252 | -2 | -0.2% | 42,900 |
| 2017/02/16 | 1,295 | 1,299 | 1,251 | 1,254 | -38 | -2.9% | 138,400 |
| 2017/02/15 | 1,259 | 1,305 | 1,253 | 1,292 | +39 | +3.1% | 373,500 |
| 2017/02/14 | 1,230 | 1,255 | 1,223 | 1,253 | +23 | +1.9% | 160,800 |
| 2017/02/13 | 1,222 | 1,233 | 1,217 | 1,230 | +6 | +0.5% | 96,700 |
| 2017/02/10 | 1,235 | 1,244 | 1,220 | 1,224 | -11 | -0.9% | 99,300 |
| 2017/02/09 | 1,228 | 1,243 | 1,221 | 1,235 | +4 | +0.3% | 74,800 |
| 2017/02/08 | 1,233 | 1,242 | 1,222 | 1,231 | -8 | -0.6% | 76,400 |
| 2017/02/07 | 1,240 | 1,248 | 1,227 | 1,239 | +7 | +0.6% | 60,200 |
| 2017/02/06 | 1,225 | 1,235 | 1,216 | 1,232 | +16 | +1.3% | 78,000 |
| 2017/02/03 | 1,222 | 1,232 | 1,207 | 1,216 | +15 | +1.2% | 150,200 |
| 2017/02/02 | 1,230 | 1,258 | 1,201 | 1,201 | -22 | -1.8% | 222,500 |
| 2017/02/01 | 1,227 | 1,239 | 1,223 | 1,223 | ±0 | ±0% | 94,800 |
| 2017/01/31 | 1,264 | 1,264 | 1,222 | 1,223 | -43 | -3.4% | 157,700 |
| 2017/01/30 | 1,239 | 1,274 | 1,239 | 1,266 | +39 | +3.2% | 190,300 |
| 2017/01/27 | 1,242 | 1,245 | 1,225 | 1,227 | -10 | -0.8% | 208,100 |
| 2017/01/26 | 1,259 | 1,261 | 1,219 | 1,237 | -17 | -1.4% | 271,200 |
| 2017/01/25 | 1,276 | 1,282 | 1,252 | 1,254 | -26 | -2% | 198,600 |
| 2017/01/24 | 1,284 | 1,288 | 1,280 | 1,280 | -4 | -0.3% | 65,100 |
| 2017/01/23 | 1,284 | 1,295 | 1,280 | 1,284 | ±0 | ±0% | 80,200 |
| 2017/01/20 | 1,289 | 1,296 | 1,284 | 1,284 | -2 | -0.2% | 68,000 |
| 2017/01/19 | 1,294 | 1,305 | 1,286 | 1,286 | -5 | -0.4% | 103,200 |
| 2017/01/18 | 1,302 | 1,306 | 1,291 | 1,291 | -4 | -0.3% | 86,700 |
| 2017/01/17 | 1,304 | 1,305 | 1,292 | 1,295 | -10 | -0.8% | 77,300 |
| 2017/01/16 | 1,305 | 1,321 | 1,295 | 1,305 | ±0 | ±0% | 108,200 |
| 2017/01/13 | 1,293 | 1,327 | 1,292 | 1,305 | -1 | -0.1% | 106,700 |
| 2017/01/12 | 1,312 | 1,320 | 1,292 | 1,306 | -19 | -1.4% | 198,300 |
| 2017/01/11 | 1,312 | 1,330 | 1,311 | 1,325 | +13 | +1% | 135,300 |
| 2017/01/10 | 1,321 | 1,329 | 1,305 | 1,312 | ±0 | ±0% | 137,700 |
| 2017/01/06 | 1,338 | 1,345 | 1,309 | 1,312 | -27 | -2% | 205,900 |
| 2017/01/05 | 1,293 | 1,342 | 1,292 | 1,339 | +53 | +4.1% | 256,400 |
| 2017/01/04 | 1,303 | 1,319 | 1,286 | 1,286 | -1 | -0.1% | 245,000 |
| 2016/12/30 | 1,253 | 1,292 | 1,253 | 1,287 | +25 | +2% | 198,000 |
| 2016/12/29 | 1,259 | 1,270 | 1,248 | 1,262 | +2 | +0.2% | 300,200 |
| 2016/12/28 | 1,267 | 1,283 | 1,254 | 1,260 | -10 | -0.8% | 222,600 |
| 2016/12/27 | 1,270 | 1,298 | 1,261 | 1,270 | -1 | -0.1% | 327,600 |
| 2016/12/26 | 1,232 | 1,272 | 1,230 | 1,271 | +39 | +3.2% | 459,100 |
| 2016/12/22 | 1,225 | 1,246 | 1,205 | 1,232 | -53 | -4.1% | 643,200 |
| 2016/12/21 | 1,330 | 1,332 | 1,281 | 1,285 | -55 | -4.1% | 598,800 |
| 2016/12/20 | 1,329 | 1,342 | 1,327 | 1,340 | +19 | +1.4% | 217,400 |
| 2016/12/19 | 1,333 | 1,353 | 1,320 | 1,321 | -18 | -1.3% | 346,200 |
| 2016/12/16 | 1,359 | 1,360 | 1,331 | 1,339 | -17 | -1.3% | 185,500 |
| 2016/12/15 | 1,388 | 1,389 | 1,345 | 1,356 | -17 | -1.2% | 249,100 |
2001～
2050
件表示中 / 2463件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.80倍 | 0.81倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.88倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
